These evidences indeed proved the involvement of EBI3 in diverse cancers; however, the specific involvement of EBI3 in melanoma has not been explored, except a preliminary study based on The Cancer Genome Atlas (TCGA) hinting EBI3 as a potential biomarker in metastatic melanoma (Yonekura, 2022). This evidence concerns the gene EBI3 and melanoma.